• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有心血管疾病的COVID-19患者入住重症监护病房的临床特征及危险因素

Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases.

作者信息

He Feng, Quan Yibo, Lei Ming, Liu Riguang, Qin Shuguang, Zeng Jun, Zhao Ziwen, Yu Na, Yang Liuping, Cao Jie

机构信息

1Guangzhou First People's Hospital, The Second Affiliated Hospital of South China University of Technology, Guangzhou, China.

2Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Aging Dis. 2020 Jul 23;11(4):763-769. doi: 10.14336/AD.2020.0622. eCollection 2020 Jul.

DOI:10.14336/AD.2020.0622
PMID:32765943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7390529/
Abstract

Previous studies on coronavirus disease 2019 (COVID-19) have focused on the general population. However, cardiovascular disease (CVD) is a common comorbidity that has rarely been investigated in detail. This study aims to describe clinical characteristics and determine risk factors for intensive care unit (ICU) admission of COVID-19 patients with CVD. In this retrospective cohort study, we included 288 adult patients with COVID-19 in Guangzhou Eighth People's Hospital from January 15, 2020 to March 10, 2020. Demographic characteristics, laboratory results, radiographic findings, complications, and treatments were recorded and compared between CVD and non-CVD groups. A binary logistic regression model was used to identify risk factors associated with ICU admission for infected patients with underlying CVD. COVID-19 patients in the CVD group were older and had higher levels of troponin I (TnI), C-reactive protein (CRP), and creatinine. They were also more prone to develop into severe or critically severe cases, receive ICU admission, and require respiratory support treatment. Multivariate regression analysis showed that the following were risk factors for ICU admission in COVID-19 patients with CVD: each 1-year increase in age (odds ratio (OR), 1.08; 95% confidence interval (CI), 1.02-1.17; p = 0.018); respiratory rate over 24 times per min (OR, 25.52; 95% CI, 5.48-118.87; p < 0.0001); CRP higher than 10 mg/L (OR, 8.12; 95% CI, 1.63-40.49; p = 0.011); and TnI higher than 0.03 μg/L (OR, 9.14; 95% CI, 2.66-31.43; p < 0.0001). Older age, CRP greater than 10 mg/L, TnI higher than 0.03 μg/L, and respiratory rate over 24 times per minute were associated with increasing odds of ICU admission in COVID-19 patients with CVD. Investigating and monitoring these factors could assist in the risk stratification of COVID-19 patients with CVD at an early stage.

摘要

先前关于2019冠状病毒病(COVID-19)的研究主要集中在普通人群。然而,心血管疾病(CVD)是一种常见的合并症,很少有研究对其进行详细调查。本研究旨在描述COVID-19合并CVD患者的临床特征,并确定其入住重症监护病房(ICU)的危险因素。在这项回顾性队列研究中,我们纳入了2020年1月15日至2020年3月10日期间在广州市第八人民医院就诊的288例成年COVID-19患者。记录并比较了CVD组和非CVD组的人口统计学特征、实验室检查结果、影像学表现、并发症及治疗情况。采用二元逻辑回归模型确定合并CVD的感染患者入住ICU的相关危险因素。CVD组的COVID-19患者年龄更大,肌钙蛋白I(TnI)、C反应蛋白(CRP)和肌酐水平更高。他们也更容易发展为重症或危重症病例,需要入住ICU并接受呼吸支持治疗。多因素回归分析显示,以下因素是合并CVD的COVID-19患者入住ICU的危险因素:年龄每增加1岁(比值比(OR),1.08;95%置信区间(CI),1.02-1.17;p = 0.018);呼吸频率每分钟超过24次(OR,25.52;95%CI,5.48-118.87;p < 0.0001);CRP高于10 mg/L(OR,8.12;95%CI,1.63-40.49;p = 0.011);TnI高于0.03 μg/L(OR,9.14;95%CI,2.66-31.43;p < 0.0001)。年龄较大、CRP大于10 mg/L、TnI高于0.03 μg/L以及呼吸频率每分钟超过24次与合并CVD的COVID-19患者入住ICU的几率增加相关。对这些因素进行调查和监测有助于在早期对合并CVD的COVID-19患者进行风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a0/7390529/40c4d585ead8/ad-11-4-763-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a0/7390529/40c4d585ead8/ad-11-4-763-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a0/7390529/40c4d585ead8/ad-11-4-763-g1.jpg

相似文献

1
Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases.患有心血管疾病的COVID-19患者入住重症监护病房的临床特征及危险因素
Aging Dis. 2020 Jul 23;11(4):763-769. doi: 10.14336/AD.2020.0622. eCollection 2020 Jul.
2
Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes.伴有糖尿病的 COVID-19 患者 ICU 收治的临床特征和危险因素。
J Diabetes Res. 2020 Dec 11;2020:5237840. doi: 10.1155/2020/5237840. eCollection 2020.
3
[Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].[危重症产科患者重症监护病房延长住院时间的危险因素分析:北京3家医院5年回顾性研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Aug;23(8):449-53.
4
Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule.重症新型冠状病毒肺炎的临床诊断:一种预测规则的推导与验证
World J Clin Cases. 2021 May 6;9(13):2994-3007. doi: 10.12998/wjcc.v9.i13.2994.
5
Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.中国宜昌新冠肺炎患者血清肌钙蛋白I水平升高相关影响因素分析
Cardiovasc Diagn Ther. 2020 Aug;10(4):678-686. doi: 10.21037/cdt-20-510.
6
Obesity and Disease Severity Among Patients With COVID-19.2019冠状病毒病患者的肥胖与疾病严重程度
Cureus. 2021 Feb 5;13(2):e13165. doi: 10.7759/cureus.13165.
7
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study.中国武汉新冠肺炎的临床结局:一项大型队列研究。
Ann Intensive Care. 2020 Jul 31;10(1):99. doi: 10.1186/s13613-020-00706-3.
8
D-dimer, Troponin, and Urea Level at Presentation With COVID-19 can Predict ICU Admission: A Single Centered Study.新冠病毒病发病时的D-二聚体、肌钙蛋白和尿素水平可预测入住重症监护病房情况:一项单中心研究
Front Med (Lausanne). 2020 Dec 9;7:585003. doi: 10.3389/fmed.2020.585003. eCollection 2020.
9
[Clinical predictive value of short-term dynamic changes in platelet counts for prognosis of sepsis patients in intensive care unit: a retrospective cohort study in adults].[血小板计数短期动态变化对重症监护病房脓毒症患者预后的临床预测价值:一项针对成人的回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):301-306. doi: 10.3760/cma.j.cn121430-20190909-00069.
10
Biochemical, Hematological, and Immunological Biomarkers as Predictors for Intensive Care Unit Admission in Patients with COVID-19.生化、血液学和免疫学生物标志物作为COVID-19患者入住重症监护病房的预测指标
Oman Med J. 2022 Nov 30;37(6):e437. doi: 10.5001/omj.2022.99. eCollection 2022 Nov.

引用本文的文献

1
Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model.使用多状态模型预测库尔德斯坦省住院患者的COVID-19病情进展。
J Diabetes Metab Disord. 2025 Mar 22;24(1):88. doi: 10.1007/s40200-025-01576-x. eCollection 2025 Jun.
2
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections.关注肾上腺髓质素表达的病理生理学:严重病毒和细菌感染中的血管内皮炎症和器官损伤。
Cells. 2024 May 22;13(11):892. doi: 10.3390/cells13110892.
3
Development of Biomarkers and Prognosis Model of Mortality Risk in Patients with COVID-19.

本文引用的文献

1
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?印度的新冠疫情:生物和环境因素是否有助于遏制发病率和严重程度?
Aging Dis. 2020 May 9;11(3):480-488. doi: 10.14336/AD.2020.0402. eCollection 2020 May.
2
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
3
新型冠状病毒肺炎患者死亡风险生物标志物及预后模型的建立
J Inflamm Res. 2024 Apr 22;17:2445-2457. doi: 10.2147/JIR.S449497. eCollection 2024.
4
Early predictors of intensive care unit admission among COVID-19 patients in Qatar.卡塔尔 COVID-19 患者入住重症监护病房的早期预测指标。
Front Public Health. 2024 Mar 20;12:1278046. doi: 10.3389/fpubh.2024.1278046. eCollection 2024.
5
Expression of gene in SARS-CoV-2 variants and its relationship with progression of COVID-19.SARS-CoV-2变异株中基因的表达及其与COVID-19进展的关系。
Future Virol. 2023 Jun;18(9):563-574. doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13.
6
Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis.2019年冠状病毒病成年患者心血管并发症的患病率:一项系统评价和荟萃分析
Iran J Med Sci. 2023 May;48(3):243-267. doi: 10.30476/IJMS.2022.93701.2504.
7
Assessing Biomarkers in Viral Infection.评估病毒感染中的生物标志物。
Adv Exp Med Biol. 2023;1412:159-173. doi: 10.1007/978-3-031-28012-2_8.
8
Understanding comorbidities and health disparities related to COVID-19: a comprehensive study of 776 936 cases and 1 362 545 controls in the state of Indiana, USA.了解与2019冠状病毒病相关的合并症和健康差异:对美国印第安纳州776936例病例和1362545例对照的综合研究。
JAMIA Open. 2023 Feb 2;6(1):ooad002. doi: 10.1093/jamiaopen/ooad002. eCollection 2023 Apr.
9
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients.心肌损伤与中段肾上腺髓质素升高在确定新冠病毒患者临床结局中的协同作用。
Front Med (Lausanne). 2022 Oct 26;9:929408. doi: 10.3389/fmed.2022.929408. eCollection 2022.
10
Characteristics and outcomes of severe COVID-19 in hospitalized patients with cardiovascular diseases in the Amazonian region of Brazil: a retrospective cohort.巴西亚马逊地区住院心血管疾病患者中严重 COVID-19 的特征和结局:一项回顾性队列研究。
Sci Rep. 2022 Nov 2;12(1):18472. doi: 10.1038/s41598-022-23365-9.
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
SARS-CoV-2 刺突受体结合域与 ACE2 受体复合物的结构。
Nature. 2020 May;581(7807):215-220. doi: 10.1038/s41586-020-2180-5. Epub 2020 Mar 30.
4
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
5
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.
6
COVID-19 and Cardiovascular Disease.新型冠状病毒肺炎与心血管疾病。
Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21.
7
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响:系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
10
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.